Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00636480 | Preoperative Skin Preparation Evaluation | PHASE3 | COMPLETED | 60 | — | — | Oct 1, 2007 | Mar 1, 2008 | Nov 26, 2025 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| CHG 2%-26 ml | EXPERIMENTAL | Chlorhexidine gluconate in an aqueous base, 26 ml applicator |
| ChloraPrep 26 ml | ACTIVE_COMPARATOR | ChloraPrep One-Step 26 ml Active drug contains chlorhexidine gluconate and alcohol |
| Sterile Saline | PLACEBO_COMPARATOR | Sterile salt water administered topically. |
| Name | Type | Description |
|---|---|---|
| Chlorhexidine gluconate | DRUG | Chlorhexidine gluconate (2% w/v) in an aqueous base, 26 ml applicator. Active drug contains alcohol and the placebo contains no drug. Administered topically. |
| ChloraPrep One Step | DRUG | Administer topically |
| Sterile saline | DRUG | 0.9% NaCl solution |
Inclusion Criteria: * Free of dermatoses, cuts, lesions, or other skin disorders on or around the test sites; no exposure to topical or systemic antimicrobials, antibiotics, or steroids (other than contraceptives, for the fourteen (14) day pre-test conditioning period and must agree to abstain from...